Dallas Tissue Research
Carolyn Cook is a seasoned finance professional with extensive experience in managing financial operations and strategic planning across various industries. Currently serving as the Chief Financial Officer at Dallas Tissue Research since May 2021, Carolyn drives financial planning, performs risk management, and manages fundraising initiatives. Previous roles include Manager of Branch Services at Sterling Crane, where Carolyn oversaw contract management, and Senior Financial Analyst positions at both Spectralink Corporation and Nordstrom, focusing on financial projections and performance analysis. Carolyn's career began in accounts receivable at Gates Corporation, progressing to a leadership role within a year. Carolyn holds an M.B.A. in Finance/Business Strategy from the University of Colorado Denver and has completed executive education at the University of Chicago Booth School of Business.
This person is not in any teams
Dallas Tissue Research
DTR is a CRO specialized in non-clinical histopathology services supported by advanced staining and analysis. Our experienced team of scientists, led by pathologists, collaborate with you to help investigate your novel targets, select and evaluate new models, and understand therapeutic efficacy.